What are the recommended guidelines and medication regimen for managing adult brain-dead organ donors?

Management of Brain-Dead Organ Donors

Brain-dead organ donors require aggressive hemodynamic and metabolic management following a standardized protocol that includes volume optimization, metabolic correction, hormonal resuscitation, and judicious use of vasoactive medications to maximize organ viability and transplant outcomes. 1

Initial Conventional Management (Before Echocardiography)

The foundation of donor management begins with systematic correction of physiological derangements:

Volume and Hemodynamic Targets

• Target CVP: 6-10 mm Hg to achieve euvolemia 1
• Target MAP: ≥60 mm Hg (though hypotension remains common in practice, occurring in 24% of donors) 2
• Rapidly taper norepinephrine and epinephrine in favor of dopamine or dobutamine to avoid myocardial oxygen demand and high-energy phosphate depletion 1
• Target dopamine <10 µg/kg/min OR dobutamine <10 µg/kg/min 1

Metabolic Correction

• pH: 7.40-7.45 (correct acidosis) 1
• PO₂: >80 mm Hg with O₂ saturation >95% 1
• PCO₂: 30-35 mm Hg 1
• Hematocrit: 30% (hemoglobin 10 g/dL) 1

Critical Pitfall: High-dose β-agonists (norepinephrine, epinephrine) deplete myocardial high-energy phosphates and increase oxygen demand, potentially compromising cardiac donor viability. Switch to dopamine/dobutamine early. 1

Cardiac Assessment and Stratification

After initial stabilization, obtain echocardiography to:

• Rule out structural abnormalities (significant LVH, valvular dysfunction, congenital lesions) 1
• If LVEF ≥45%: Proceed with organ recovery (consider aggressive management to optimize function) 1
• If LVEF <45%: Implement aggressive management with pulmonary artery catheter placement and hormonal resuscitation 1

Important Caveat: A single echocardiographic assessment may be inaccurate and fails to predict long-term ventricular function. Do not decline organs based solely on initial ejection fraction—92% of organs failing initial criteria can be functionally resuscitated with proper management. 1

Hormonal Resuscitation Protocol

For donors with LVEF <45% or hemodynamic instability, implement the following hormonal therapy: 1

Specific Medication Regimen

1. Triiodothyronine (T3):

   • 4 µg bolus
   • Continuous infusion at 3 µg/h 1

2. Arginine Vasopressin:

   • 1 unit bolus
   • Continuous infusion at 0.5-4 units/h
   • Titrate to SVR: 800-1200 dyne·s⁻¹·cm⁻⁵ 1

3. Methylprednisolone:

   • 15 mg/kg bolus 1

Evidence Base: This combined hormonal approach improves ventricular performance, raises systolic blood pressure, and reduces inotropic requirements by correcting the hormonal perturbations that occur after brain death. 1

Advanced Hemodynamic Management

When hormonal resuscitation is initiated, place a pulmonary artery catheter for guided management. The Papworth program demonstrated that this approach increased donor yield by 30% through functional resuscitation of initially unsuitable organs. 1

Additional Medications

• Insulin: Minimum 1 unit/h, titrated to blood glucose control 1
• Crystalloids: Balanced crystalloids preferred (58% use), though practice varies between normal saline and albumin 3

Ventilation Strategy

Implement protective mechanical ventilation: 3

• Tidal volume: ≤6 mL/kg
• PEEP: ≤10 cmH₂O

This approach is well-understood and widely implemented to preserve lung function for transplantation.

Intraoperative Management

During organ recovery procedures, donors commonly receive: 2

• Heparin (96.4%) - anticoagulation for organ preservation
• Neuromuscular blockers (89.5%) - prevent reflex movements
• Vasoactive medications (82.7%) - maintain hemodynamics
• Halogenated anesthetic gases (63.5%) - though not universally used
• Diuretics (43.8%) and steroids (16.7%) - significant practice variation exists

Notable Practice Variation: Steroid and diuretic use shows the largest heterogeneity between centers (ICCs 0.65 and 0.44 respectively), suggesting lack of standardization in these areas. 2

Key Management Principles

The overarching goals are: 1

• Achieve euvolemia without fluid overload
• Maintain normal afterload (avoid excessive vasoconstriction)
• Optimize cardiac output without high-dose inotropes
• Correct all metabolic derangements
• Address hormonal perturbations from brain death

Critical Point: The care provided to one organ donor is equivalent to caring for multiple transplant recipients. Aggressive donor management ensures maximum organ procurement and improves overall organ quality. 4

Organizational Considerations

• Use standardized protocols accepted by regional organ recovery teams 1
• Involve specialists (cardiologists, pulmonologists, intensivists, surgeons) in donor management 1
• Implement early brain death diagnosis to allow adequate time for optimization 5

Current Gap: Despite guideline recommendations for MAP >60 mm Hg, hypotension during recovery remains common (24% of cases), indicating need for improved adherence to protocols. 2